David P. Meeker, Director at Trevi Therapeutics, Inc. (TRVI), sold 4,555 shares at $2.93 ($13K) on 2024-08-27, disclosed to the SEC on 2024-08-29.
Open-market sale of $13k TRVI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RYTM | SELL | 2025-02-19 | $1.1M | — | Filing → |
| RYTM | SELL | 2025-02-04 | $508K | — | Filing → |
| RYTM | SELL | 2024-03-19 | $3.6M | — | Filing → |